Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin
- PMID: 7798230
Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin
Abstract
The physiological alpha-oxoaldehyde methylglyoxal binds and modifies arginine, lysine, and cysteine residues in proteins. The kinetics and mechanism of these reactions were investigated with N alpha-acetylamino acids and bovine serum albumin at pH 7.4 and 37 degrees C. The reaction of methylglyoxal with N alpha-acetylarginine involved the initial reversible formation of glycosylamine and 4,5-dihydroxy-5-methylimidazolidine derivatives, with further slow irreversible conversion to an imidazolone, N alpha-acetyl-N delta- (5-methyl-4-imidazolon-2-yl)ornithine. The imidazolone was fluorescent with an excitation lambda max value of 320 nm and an emission lambda max value of 398 nm. Methylglyoxal reacted reversibly with N alpha-acetyllysine to form glycosylamine and bisglycosylamine derivatives. Further reaction of these glycosylamines occurred to form brown, fluorescent oligomers that were not characterized. Methylglyoxal reacted rapidly and reversibly with N alpha-acetylcysteine to form the hemithioacetal adduct. The reaction of methylglyoxal with bovine serum albumin (BSA) at pH 7.4 and 37 degrees C involved the reversible and irreversible formation of methylglyoxal-BSA adducts. Irreversible modification of BSA occurred mainly on arginine residues to form imidazolone. The formation of methylglyoxal-modified proteins involves glycoxidation leading to advanced glycation end product-like fluorescence. It is expected to be increased in diabetes mellitus and may be linked to the development of diabetic complications.
Similar articles
-
Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins.J Protein Chem. 1995 Jul;14(5):359-72. doi: 10.1007/BF01886793. J Protein Chem. 1995. PMID: 8590604
-
Receptor-mediated endocytic uptake of methylglyoxal-modified serum albumin. Competition with advanced glycation end product-modified serum albumin at the advanced glycation end product receptor.J Biol Chem. 1994 Dec 23;269(51):32293-8. J Biol Chem. 1994. PMID: 7798229
-
Methylglyoxal-modified arginine residues--a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells.Biochim Biophys Acta. 1997 Mar 27;1356(1):84-94. doi: 10.1016/s0167-4889(96)00154-1. Biochim Biophys Acta. 1997. PMID: 9099994
-
Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.Gen Pharmacol. 1996 Jun;27(4):565-73. doi: 10.1016/0306-3623(95)02054-3. Gen Pharmacol. 1996. PMID: 8853285 Review.
-
New biomarkers of Maillard reaction damage to proteins.Nephrol Dial Transplant. 1996;11 Suppl 5:41-7. doi: 10.1093/ndt/11.supp5.41. Nephrol Dial Transplant. 1996. PMID: 9044306 Review.
Cited by
-
Mass spectrometric determination of early and advanced glycation in biology.Glycoconj J. 2016 Aug;33(4):553-68. doi: 10.1007/s10719-016-9709-8. Epub 2016 Jul 20. Glycoconj J. 2016. PMID: 27438287 Free PMC article. Review.
-
Semiquantitative analysis of apolipoprotein A-I modified by advanced glycation end products in diabetes mellitus.J Clin Lab Anal. 2013 May;27(3):231-6. doi: 10.1002/jcla.21591. Epub 2013 Feb 25. J Clin Lab Anal. 2013. PMID: 23440769 Free PMC article.
-
Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.Mol Neurobiol. 2018 Nov;55(11):8754-8763. doi: 10.1007/s12035-018-1025-9. Epub 2018 Mar 28. Mol Neurobiol. 2018. PMID: 29594935 Review.
-
Mutagenesis of residue 157 in the active site of human glyoxalase I.Biochem J. 1997 Nov 15;328 ( Pt 1)(Pt 1):231-5. doi: 10.1042/bj3280231. Biochem J. 1997. PMID: 9359858 Free PMC article.
-
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.J Clin Invest. 1997 Mar 15;99(6):1272-80. doi: 10.1172/JCI119285. J Clin Invest. 1997. PMID: 9077536 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
